{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:50:49Z","timestamp":1793152249177,"version":"4.5.0"},"reference-count":160,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.neulet.2019.134306","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T20:08:54Z","timestamp":1559938134000},"page":"134306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["Peripheral versus central nervous system APOE in Alzheimer\u2019s disease: Interplay across the blood-brain barrier"],"prefix":"10.1016","volume":"708","author":[{"given":"Dustin","family":"Chernick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Ortiz-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9245-7387","authenticated-orcid":false,"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2019.134306_bib0005","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.neulet.2019.134306_bib0010","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1161\/ATVBAHA.116.307023","article-title":"Central nervous system lipoproteins: ApoE and regulation of cholesterol metabolism","volume":"36","author":"Mahley","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.neulet.2019.134306_bib0015","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006312","article-title":"Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease","volume":"2","author":"Holtzman","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neulet.2019.134306_bib0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.biopsych.2017.03.003","article-title":"Apolipoprotein E, Receptors, and Modulation of Alzheimer\u2019s Disease","volume":"83","author":"Zhao","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2019.134306_bib0025","doi-asserted-by":"crossref","first-page":"9077","DOI":"10.1016\/S0021-9258(19)52510-8","article-title":"Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms","volume":"256","author":"Weisgraber","year":"1981","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.134306_bib0030","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1016\/S0021-9258(18)34702-1","article-title":"Human apolipoprotein E. The complete amino acid sequence","volume":"257","author":"Rall","year":"1982","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.134306_bib0035","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00109-016-1427-y","article-title":"Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders","volume":"94","author":"Mahley","year":"2016","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.neulet.2019.134306_bib0040","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.neulet.2019.134306_bib0045","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","article-title":"Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer\u2019s disease","volume":"43","author":"Saunders","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2019.134306_bib0050","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Pt A","key":"10.1016\/j.neulet.2019.134306_bib0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nbd.2014.07.015","article-title":"HDL and cognition in neurodegenerative disorders","volume":"72","author":"Hottman","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2019.134306_bib0060","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cvr\/cvu148","article-title":"HDL and cholesterol handling in the brain","volume":"103","author":"Vitali","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.neulet.2019.134306_bib0065","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1172\/JCI115288","article-title":"Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation","volume":"88","author":"Linton","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neulet.2019.134306_bib0070","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","article-title":"Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus","volume":"26","author":"Xu","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134306_bib0075","doi-asserted-by":"crossref","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","article-title":"An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex","volume":"34","author":"Zhang","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134306_bib0080","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","article-title":"ApoE and Abeta in Alzheimer\u2019s Disease: Accidental Encounters or Partners?","volume":"81","author":"Kanekiyo","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2019.134306_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079908","article-title":"ApoE production in human monocytes and its regulation by inflammatory cytokines","volume":"8","author":"Braesch-Andersen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2019.134306_bib0090","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00109-018-1632-y","article-title":"Cell-specific production, secretion, and function of apolipoprotein E","volume":"96","author":"Kockx","year":"2018","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.neulet.2019.134306_bib0095","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0022-2275(20)31605-9","article-title":"Characterization of four lipoprotein classes in human cerebrospinal fluid","volume":"42","author":"Koch","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.neulet.2019.134306_bib0100","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00001756-200303240-00016","article-title":"Apolipoprotein E (APOE) polymorphism influences serum APOE levels in Alzheimer\u2019s disease patients and centenarians","volume":"14","author":"Panza","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.neulet.2019.134306_bib0105","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1172\/JCI118098","article-title":"Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation","volume":"96","author":"Boisvert","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neulet.2019.134306_bib0110","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1126\/science.7863332","article-title":"Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation","volume":"267","author":"Linton","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.neulet.2019.134306_bib0115","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1523\/JNEUROSCI.3253-07.2008","article-title":"Intron-3 retention\/splicing controls neuronal expression of apolipoprotein E in the CNS","volume":"28","author":"Xu","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134306_bib0120","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1161\/ATVBAHA.108.164350","article-title":"Regulation of endogenous apolipoprotein E secretion by macrophages","volume":"28","author":"Kockx","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.neulet.2019.134306_bib0125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.expneurol.2016.04.014","article-title":"Identification and modification of amyloid-independent phenotypes of APOE4 mice","volume":"280","author":"DiBattista","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neulet.2019.134306_bib0130","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1093\/hmg\/dds296","article-title":"Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer\u2019s disease","volume":"21","author":"Cruchaga","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neulet.2019.134306_bib0135","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00401-014-1266-2","article-title":"Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer\u2019s disease patients and controls","volume":"127","author":"Martinez-Morillo","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neulet.2019.134306_bib0140","doi-asserted-by":"crossref","first-page":"27204","DOI":"10.1074\/jbc.M116.721779","article-title":"Human Central Nervous System (CNS) ApoE Isoforms Are Increased by Age, Differentially Altered by Amyloidosis, and Relative Amounts Reversed in the CNS Compared with Plasma","volume":"291","author":"Baker-Nigh","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.134306_bib0145","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ana.24326","article-title":"Plasma levels of apolipoprotein E and risk of dementia in the general population","volume":"77","author":"Rasmussen","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2019.134306_bib0150","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neulet.2016.02.018","article-title":"Serum apolipoprotein E is associated with long-term risk of Alzheimer\u2019s disease: the Rotterdam Study","volume":"617","author":"Wolters","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2019.134306_bib0155","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jalz.2017.05.006","article-title":"Plasma apolipoprotein E levels and risk of dementia: a Mendelian randomization study of 106,562 individuals","volume":"14","author":"Rasmussen","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neulet.2019.134306_bib0160","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1411543","article-title":"Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E","volume":"258","author":"Zhang","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neulet.2019.134306_bib0165","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0092-8674(92)90362-G","article-title":"Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells","volume":"71","author":"Plump","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.neulet.2019.134306_bib0170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00041433-200104000-00003","article-title":"Cholesterol metabolism in the brain","volume":"12","author":"Dietschy","year":"2001","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.neulet.2019.134306_bib0175","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","article-title":"Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal","volume":"45","author":"Dietschy","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.neulet.2019.134306_bib0180","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1046\/j.1471-4159.2000.0741008.x","article-title":"Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture","volume":"74","author":"Michikawa","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2019.134306_bib0185","doi-asserted-by":"crossref","first-page":"29919","DOI":"10.1074\/jbc.M203934200","article-title":"Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice","volume":"277","author":"Gong","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.134306_bib0190","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-1326-9-2","article-title":"Soluble apoE\/Abeta complex: mechanism and therapeutic target for APOE4-induced AD risk","volume":"9","author":"Tai","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neulet.2019.134306_bib0195","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13024-015-0001-3","article-title":"Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Abeta metabolism in apoE4-targeted replacement mice","volume":"10","author":"Hu","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neulet.2019.134306_bib0200","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/jamaneurol.2013.396","article-title":"Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial","volume":"70","author":"Hanson","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neulet.2019.134306_bib0205","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/jnen\/nlw067","article-title":"Apolipoprotein e genotype affects size of ApoE complexes in cerebrospinal fluid","volume":"75","author":"Heinsinger","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neulet.2019.134306_bib0210","doi-asserted-by":"crossref","first-page":"11965","DOI":"10.1073\/pnas.1510011112","article-title":"Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in Alzheimer\u2019s disease pathogenesis","volume":"112","author":"Zhu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Pt A","key":"10.1016\/j.neulet.2019.134306_bib0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2014.08.025","article-title":"Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer\u2019s diseases","volume":"72","author":"Huang","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2019.134306_bib0220","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/MOL.0000000000000383","article-title":"Apolipoprotein E metabolism and functions in brain and its role in Alzheimer\u2019s disease","volume":"28","author":"Liao","year":"2017","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.neulet.2019.134306_bib0225","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apolipoprotein E in Alzheimer\u2019s disease","volume":"63","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2019.134306_bib0230","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","article-title":"ApoE4 accelerates early seeding of amyloid pathology","volume":"96","author":"Liu","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2019.134306_bib0235","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.neuron.2017.11.014","article-title":"Age-dependent effects of apoE reduction using antisense oligonucleotides in a model of beta-amyloidosis","volume":"96","author":"Huynh","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2019.134306_bib0240","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41557-018-0031-x","article-title":"Cholesterol catalyses Abeta42 aggregation through a heterogeneous nucleation pathway in the presence of lipid membranes","volume":"10","author":"Habchi","year":"2018","journal-title":"Nat. Chem."},{"key":"10.1016\/j.neulet.2019.134306_bib0245","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cell.2016.12.044","article-title":"ApoE4 differentially stimulate APP transcription and abeta secretion","volume":"168","author":"Huang","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.neulet.2019.134306_bib0250","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","article-title":"Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector","volume":"24","author":"Wang","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.neulet.2019.134306_bib0255","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","article-title":"APOE4 causes widespread molecular and cellular alterations associated with alzheimer\u2019s disease phenotypes in human iPSC-Derived brain cell types","volume":"98","author":"Lin","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2019.134306_bib0260","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2019.134306_bib0265","doi-asserted-by":"crossref","first-page":"11372","DOI":"10.1038\/s41598-017-11654-7","article-title":"ApoE4-associated phospholipid dysregulation contributes to development of Tau hyper-phosphorylation after traumatic brain injury","volume":"7","author":"Cao","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neulet.2019.134306_bib0270","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3233\/JAD-2012-120973","article-title":"Lymphocytes from young healthy persons carrying the ApoE4 allele overexpress stress-related proteins involved in the pathophysiology of Alzheimer\u2019s disease","volume":"33","author":"Badia","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neulet.2019.134306_bib0275","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1038\/s41467-018-06783-0","article-title":"APOE epsilon2 is associated with increased tau pathology in primary tauopathy","volume":"9","author":"Zhao","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neulet.2019.134306_bib0280","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neurobiolaging.2015.09.011","article-title":"Association of APOE with tau-tangle pathology with and without beta-amyloid","volume":"37","author":"Farfel","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2019.134306_bib0285","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/42257","article-title":"Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E","volume":"388","author":"Barger","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2019.134306_bib0290","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-5728(00)00459-8","article-title":"Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response","volume":"114","author":"Lynch","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neulet.2019.134306_bib0295","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.neurobiolaging.2007.11.014","article-title":"APOE genotype-specific differences in the innate immune response","volume":"30","author":"Vitek","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2019.134306_bib0300","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jaci.2014.01.032","article-title":"APOepsilon4 is associated with enhanced in vivo innate immune responses in human subjects","volume":"134","author":"Gale","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.neulet.2019.134306_bib0305","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1161\/CIRCULATIONAHA.115.015489","article-title":"Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease","volume":"131","author":"Desikan","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.neulet.2019.134306_bib0310","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1212\/01.wnl.0000263217.36439.da","article-title":"Inflammatory markers and the risk of Alzheimer disease: the Framingham Study","volume":"68","author":"Tan","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2019.134306_bib0315","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0891988709351832","article-title":"Decreased C-reactive protein levels in Alzheimer disease","volume":"23","author":"O\u2019Bryant","year":"2010","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.neulet.2019.134306_bib0320","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1212\/WNL.0b013e318266fa70","article-title":"Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease","volume":"79","author":"Hu","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2019.134306_bib0325","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.10265","article-title":"Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study","volume":"52","author":"Schmidt","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2019.134306_bib0330","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/archneur.61.5.668","article-title":"Inflammatory proteins in plasma and the risk of dementia: the rotterdam study","volume":"61","author":"Engelhart","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neulet.2019.134306_bib0335","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.neurobiolaging.2008.01.014","article-title":"Inflammatory markers in AD and MCI patients with different biomarker profiles","volume":"30","author":"Schuitemaker","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2019.134306_bib0340","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.3597","article-title":"Association of chronic low-grade inflammation with risk of alzheimer disease in ApoE4 carriers","volume":"1","author":"Tao","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.neulet.2019.134306_bib0345","article-title":"Few serum proteins mediate APOE\u2019s association with dementia","volume":"12","author":"Royall","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2019.134306_bib0350","doi-asserted-by":"crossref","DOI":"10.1177\/1759091417719201","article-title":"Apolipoprotein E4, and amyloid-beta interact to induce cognitive and cerebrovascular dysfunction","volume":"9","author":"Marottoli","year":"2017","journal-title":"ASN Neuro"},{"key":"10.1016\/j.neulet.2019.134306_bib0355","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/WNR.0000000000000608","article-title":"Apolipoprotein E isotype-dependent modulation of microRNA-146a in plasma and brain","volume":"27","author":"Teter","year":"2016","journal-title":"Neuroreport"},{"key":"10.1016\/j.neulet.2019.134306_bib0360","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"G. Alzheimer genetic analysis, TREM2 variants in alzheimer\u2019s disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neulet.2019.134306_bib0365","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer\u2019s disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neulet.2019.134306_bib0370","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrn.2016.7","article-title":"TREM2 variants: new keys to decipher Alzheimer disease pathogenesis","volume":"17","author":"Colonna","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neulet.2019.134306_bib0375","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuron.2017.02.042","article-title":"Elucidating the role of TREM2 in alzheimer\u2019s disease","volume":"94","author":"Ulrich","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2019.134306_bib0380","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.molmed.2017.03.008","article-title":"TREM2, microglia, and neurodegenerative diseases","volume":"23","author":"Yeh","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neulet.2019.134306_bib0385","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13024-017-0197-5","article-title":"TREM2 in neurodegenerative diseases","volume":"12","author":"Jay","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neulet.2019.134306_bib0390","doi-asserted-by":"crossref","first-page":"26043","DOI":"10.1074\/jbc.M115.679043","article-title":"Apolipoprotein e is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2)","volume":"290","author":"Atagi","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.134306_bib0395","doi-asserted-by":"crossref","first-page":"26033","DOI":"10.1074\/jbc.M115.677286","article-title":"The triggering receptor expressed on myeloid cells 2 binds apolipoprotein e","volume":"290","author":"Bailey","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.134306_bib0400","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.neulet.2019.134306_bib0405","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","article-title":"TREM2 binds to Apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia","volume":"91","author":"Yeh","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2019.134306_bib0410","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12974-017-0835-4","article-title":"The Alzheimer\u2019s disease risk factors apolipoprotein E and TREM2 are linked in a receptor signaling pathway","volume":"14","author":"Jendresen","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neulet.2019.134306_bib0415","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of alzheimer\u2019s disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.neulet.2019.134306_bib0420","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1084\/jem.20180653","article-title":"Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau","volume":"215","author":"Kang","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neulet.2019.134306_bib0425","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41593-018-0296-9","article-title":"Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE","volume":"22","author":"Parhizkar","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neulet.2019.134306_bib0430","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1084\/jem.20171265","article-title":"ApoE facilitates the microglial response to amyloid plaque pathology","volume":"215","author":"Ulrich","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neulet.2019.134306_bib0435","article-title":"Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight, Nature reviews","author":"Shi","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.neulet.2019.134306_bib0440","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.jmb.2017.04.004","article-title":"TREM2-ligand interactions in health and disease","volume":"429","author":"Kober","year":"2017","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.neulet.2019.134306_bib0445","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3233\/JAD-130854","article-title":"Increased expression of TREM2 in peripheral blood of Alzheimer\u2019s disease patients","volume":"38","author":"Hu","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neulet.2019.134306_bib0450","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/ene.13583","article-title":"Increased expression of TREM2 in peripheral cells from mild cognitive impairment patients who progress into Alzheimer\u2019s disease","volume":"25","author":"Casati","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neulet.2019.134306_bib0455","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer\u2019s amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neulet.2019.134306_bib0460","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neulet.2019.134306_bib0465","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1084\/jem.20171406","article-title":"Alzheimer\u2019s disease: A matter of blood-brain barrier dysfunction?","volume":"214","author":"Montagne","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neulet.2019.134306_bib0470","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/s41593-018-0234-x","article-title":"The role of brain vasculature in neurodegenerative disorders","volume":"21","author":"Sweeney","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neulet.2019.134306_bib0475","first-page":"133","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders, Nature reviews","volume":"14","author":"Sweeney","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2019.134306_bib0480","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/jamaneurol.2014.681","article-title":"Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease","volume":"71","author":"Ringman","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neulet.2019.134306_bib0485","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/bpa.12221","article-title":"Cerebral amyloid angiopathy, subcortical white matter disease and dementia: literature review and study in OPTIMA","volume":"25","author":"Esiri","year":"2015","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neulet.2019.134306_bib0490","doi-asserted-by":"crossref","first-page":"C1256","DOI":"10.1152\/ajpcell.00563.2005","article-title":"ApoE deficiency leads to a progressive age-dependent blood-brain barrier leakage","volume":"292","author":"Hafezi-Moghadam","year":"2007","journal-title":"Am. J. Physiol., Cell Physiol."},{"key":"10.1016\/j.neulet.2019.134306_bib0495","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/BF03401973","article-title":"ApoE deficiency compromises the blood brain barrier especially after injury","volume":"7","author":"Methia","year":"2001","journal-title":"Mol Med"},{"key":"10.1016\/j.neulet.2019.134306_bib0500","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/exnr.2001.7631","article-title":"Impairment of the blood-nerve and blood-brain barriers in apolipoprotein e knockout mice","volume":"169","author":"Fullerton","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neulet.2019.134306_bib0505","doi-asserted-by":"crossref","first-page":"17536","DOI":"10.1074\/jbc.M111.225532","article-title":"Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model","volume":"286","author":"Nishitsuji","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.134306_bib0510","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature11087","article-title":"Apolipoprotein E controls cerebrovascular integrity via cyclophilin A","volume":"485","author":"Bell","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2019.134306_bib0515","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/jcbfm.2014.172","article-title":"Human apolipoprotein E varepsilon4 expression impairs cerebral vascularization and blood-brain barrier function in mice","volume":"35","author":"Alata","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neulet.2019.134306_bib0520","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.29595","article-title":"Clearance of beta-amyloid is facilitated by apolipoprotein E and circulating high-density lipoproteins in bioengineered human vessels","volume":"6","author":"Robert","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.neulet.2019.134306_bib0525","series-title":"ApoE Has Hand in Alzheimer\u2019s Beyond A\u03b2, Beyond the Brain","author":"Shugart","year":"2018"},{"key":"10.1016\/j.neulet.2019.134306_bib0530","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13024-018-0286-0","article-title":"Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-beta42 by LRP1-dependent apolipoprotein E isoform-specific mechanism","volume":"13","author":"Ma","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neulet.2019.134306_bib0535","doi-asserted-by":"crossref","first-page":"767","DOI":"10.14348\/molcells.2014.0248","article-title":"Apolipoprotein E in synaptic plasticity and Alzheimer\u2019s disease: potential cellular and molecular mechanisms","volume":"37","author":"Kim","year":"2014","journal-title":"Mol. Cells"},{"key":"10.1016\/j.neulet.2019.134306_bib0540","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.2174\/1567205013666160401115127","article-title":"Alzheimer\u2019s disease genetic risk factor APOE-epsilon4 also affects normal brain function","volume":"13","author":"Di Battista","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neulet.2019.134306_bib0545","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1097\/00001756-200412030-00020","article-title":"ApoE isoform affects LTP in human targeted replacement mice","volume":"15","author":"Trommer","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.neulet.2019.134306_bib0550","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.nbd.2004.08.011","article-title":"ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-beta1-42","volume":"18","author":"Trommer","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2019.134306_bib0555","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1326-4-21","article-title":"ApoE isoform-dependent changes in hippocampal synaptic function","volume":"4","author":"Korwek","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neulet.2019.134306_bib0560","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/35006165","article-title":"Apolipoprotein E and cognitive performance","volume":"404","author":"Raber","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2019.134306_bib0565","doi-asserted-by":"crossref","first-page":"13707","DOI":"10.1523\/JNEUROSCI.4040-10.2010","article-title":"Apolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice","volume":"30","author":"Andrews-Zwilling","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134306_bib0570","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0197-4580(01)00223-8","article-title":"Memory performance in healthy elderly without Alzheimer\u2019s disease: effects of time and apolipoprotein-E","volume":"22","author":"Mayeux","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2019.134306_bib0575","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1212\/WNL.57.12.2217","article-title":"Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly","volume":"57","author":"Dik","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2019.134306_bib0580","doi-asserted-by":"crossref","first-page":"12011","DOI":"10.1073\/pnas.0914984107","article-title":"ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling","volume":"107","author":"Chen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2019.134306_bib0585","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053569","article-title":"Apolipoprotein E4 causes age- and sex-dependent impairments of hilar GABAergic interneurons and learning and memory deficits in mice","volume":"7","author":"Leung","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2019.134306_bib0590","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1523\/JNEUROSCI.3815-15.2016","article-title":"Enhancing GABA signaling during middle adulthood prevents age-dependent GABAergic interneuron decline and learning and memory deficits in ApoE4 mice","volume":"36","author":"Tong","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134306_bib0595","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/s41467-017-01444-0","article-title":"Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer\u2019s disease-like pathology","volume":"8","author":"Nuriel","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neulet.2019.134306_bib0600","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.neuron.2016.04.009","article-title":"Apolipoprotein E4 causes age-dependent disruption of slow gamma oscillations during Hippocampal sharp-wave ripples","volume":"90","author":"Gillespie","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2019.134306_bib0605","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neurobiolaging.2017.02.017","article-title":"Plasma apolipoproteins and physical and cognitive health in very old individuals","volume":"55","author":"Muenchhoff","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2019.134306_bib0610","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13195-016-0231-9","article-title":"3rd, E. Reiman, R. Caselli, G. Bu, Peripheral apoE isoform levels in cognitively normal APOE epsilon3\/epsilon4 individuals are associated with regional gray matter volume and cerebral glucose metabolism","volume":"9","author":"Nielsen","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neulet.2019.134306_bib0615","doi-asserted-by":"crossref","first-page":"10141","DOI":"10.1523\/JNEUROSCI.1054-16.2016","article-title":"Genetic restoration of plasma ApoE improves cognition and partially restores synaptic defects in ApoE-Deficient mice","volume":"36","author":"Lane-Donovan","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134306_bib0620","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/jamaneurol.2014.2013","article-title":"Is apolipoprotein e required for cognitive function in humans?: implications for Alzheimer drug development","volume":"71","author":"Lane-Donovan","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neulet.2019.134306_bib0625","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1172\/JCI112704","article-title":"Familial apolipoprotein e deficiency","volume":"78","author":"Schaefer","year":"1986","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neulet.2019.134306_bib0630","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/jamaneurol.2014.2011","article-title":"Effects of the absence of apolipoprotein e on lipoproteins, neurocognitive function, and retinal function","volume":"71","author":"Mak","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neulet.2019.134306_bib0635","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1084\/jem.20121274","article-title":"Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Abeta amyloidosis","volume":"209","author":"Kim","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neulet.2019.134306_bib0640","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0646-14.2014","article-title":"Anti-ApoE antibody given after plaque onset decreases Abeta accumulation and improves brain function in a mouse model of Abeta amyloidosis","volume":"34","author":"Liao","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134306_bib0645","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1172\/JCI96429","article-title":"Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation","volume":"128","author":"Liao","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neulet.2019.134306_bib0650","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1194\/jlr.R075556","article-title":"Therapeutic potential of nuclear receptor agonists in Alzheimer\u2019s disease","volume":"58","author":"Moutinho","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.neulet.2019.134306_bib0655","doi-asserted-by":"crossref","first-page":"924-e","DOI":"10.1126\/science.1233937","article-title":"Comment on \"ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models","volume":"340","author":"Tesseur","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.neulet.2019.134306_bib0660","doi-asserted-by":"crossref","first-page":"924-f","DOI":"10.1126\/science.1235505","article-title":"Comment on \"ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models","volume":"340","author":"Veeraraghavalu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.neulet.2019.134306_bib0665","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13195-016-0173-2","article-title":"Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer\u2019s disease","volume":"8","author":"Cummings","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neulet.2019.134306_bib0670","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1523\/JNEUROSCI.5198-13.2014","article-title":"Reversal of apoE4-driven brain pathology and behavioral deficits by bexarotene","volume":"34","author":"Boehm-Cagan","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134306_bib0675","doi-asserted-by":"crossref","first-page":"11862","DOI":"10.1523\/JNEUROSCI.1001-15.2015","article-title":"Bexarotene-Activated Retinoid X Receptors Regulate Neuronal Differentiation and Dendritic Complexity","volume":"35","author":"Mounier","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.134306_bib0680","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nrd4280","article-title":"Liver X receptors in lipid metabolism: opportunities for drug discovery","volume":"13","author":"Hong","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neulet.2019.134306_bib0685","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2147\/NDT.S61309","article-title":"The emerging role of bexarotene in the treatment of Alzheimer\u2019s disease: current evidence","volume":"11","author":"Tousi","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neulet.2019.134306_bib0690","doi-asserted-by":"crossref","first-page":"30538","DOI":"10.1074\/jbc.M114.600833","article-title":"Amyloid-beta pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo","volume":"289","author":"Tai","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.134306_bib0695","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.nbd.2009.03.007","article-title":"Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer\u2019s disease","volume":"34","author":"Handattu","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2019.134306_bib0700","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3233\/JAD-122377","article-title":"In vivo and in vitro effects of an apolipoprotein e mimetic peptide on amyloid-beta pathology","volume":"36","author":"Handattu","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neulet.2019.134306_bib0705","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3233\/JAD-160467","article-title":"ABCA1 agonist reverses the ApoE4-Driven cognitive and brain pathologies","volume":"54","author":"Boehm-Cagan","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neulet.2019.134306_bib0710","doi-asserted-by":"crossref","first-page":"46461","DOI":"10.1038\/srep46461","article-title":"Neuroprotective pentapeptide CN-105 is associated with reduced sterile inflammation and improved functional outcomes in a traumatic brain injury murine model","volume":"7","author":"Laskowitz","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neulet.2019.134306_bib0715","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000334914","article-title":"APOE-mimetic peptides reduce behavioral deficits, plaques and tangles in Alzheimer\u2019s disease transgenics","volume":"10","author":"Vitek","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neulet.2019.134306_bib0720","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000341299","article-title":"The apolipoprotein-E-mimetic COG112 protects amyloid precursor protein intracellular domain-overexpressing animals from Alzheimer\u2019s disease-like pathological features","volume":"12","author":"Ghosal","year":"2013","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neulet.2019.134306_bib0725","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188191","article-title":"Effects of an Abeta-antibody fragment on Abeta aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides","volume":"12","author":"Montoliu-Gaya","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2019.134306_bib0730","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mcn.2018.03.015","article-title":"Abeta-oligomer uptake and the resulting inflammatory response in adult human astrocytes are precluded by an anti-Abeta single chain variable fragment in combination with an apoE mimetic peptide","volume":"89","author":"Montoliu-Gaya","year":"2018","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neulet.2019.134306_bib0735","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1194\/jlr.P800003-JLR200","article-title":"Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients","volume":"49","author":"Bloedon","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.neulet.2019.134306_bib0740","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1194\/jlr.M011098","article-title":"Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function","volume":"52","author":"Watson","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.neulet.2019.134306_bib0745","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/cts.12487","article-title":"Oral apolipoprotein A-I mimetic D-4F lowers HDL-Inflammatory index in high-risk patients: a first-in-Human multiple-dose, randomized controlled trial","volume":"10","author":"Dunbar","year":"2017","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.neulet.2019.134306_bib0750","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/jnc.14554","article-title":"High-density lipoprotein mimetic peptide 4F mitigates amyloid-beta-induced inhibition of apolipoprotein E secretion and lipidation in primary astrocytes and microglia","volume":"147","author":"Chernick","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2019.134306_bib0755","article-title":"A clinically tested HDL mimetic peptide mitigates apoE4 associated lipidation and memory deficits","author":"Chernick","year":"2018","journal-title":"Program No. 746.11. 2018 Neuroscience Meeting Planner"},{"key":"10.1016\/j.neulet.2019.134306_bib0760","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1073\/pnas.0600549103","article-title":"Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer\u2019s disease","volume":"103","author":"Mahley","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2019.134306_bib0765","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1074\/jbc.R800009200","article-title":"Understanding the association of apolipoprotein E4 with Alzheimer disease: clues from its structure","volume":"284","author":"Zhong","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.134306_bib0770","doi-asserted-by":"crossref","first-page":"8997","DOI":"10.1021\/jm3008618","article-title":"Small-molecule structure correctors target abnormal protein structure and function: structure corrector rescue of apolipoprotein E4-associated neuropathology","volume":"55","author":"Mahley","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neulet.2019.134306_bib0775","first-page":"24","article-title":"AAVrh.10-mediated APOE2 central nervous system gene therapy for APOE4-Associated alzheimer\u2019s disease, human gene therapy","volume":"29","author":"Rosenberg","year":"2018","journal-title":"Clinical development"},{"key":"10.1016\/j.neulet.2019.134306_bib0780","doi-asserted-by":"crossref","first-page":"10796","DOI":"10.1016\/S0021-9258(18)99088-5","article-title":"Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice","volume":"266","author":"Agellon","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2019.134306_bib0785","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s40478-015-0250-y","article-title":"Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models","volume":"3","author":"Liao","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neulet.2019.134306_bib0790","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1471-4159.2007.04831.x","article-title":"Important differences between human and mouse APOE gene promoters: limitation of mouse APOE model in studying Alzheimer\u2019s disease","volume":"103","author":"Maloney","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2019.134306_bib0795","doi-asserted-by":"crossref","first-page":"11587","DOI":"10.1073\/pnas.201279298","article-title":"Introduction of human apolipoprotein E4\u2033domain interaction\" into mouse apolipoprotein E","volume":"98","author":"Raffai","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2019.134306_bib0800","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.atherosclerosis.2013.11.080","article-title":"The influence of apoE-deficiency and LDL-receptor-deficiency on the HDL subpopulation profile in mice and in humans","volume":"233","author":"Tani","year":"2014","journal-title":"Atherosclerosis"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019303799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019303799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:27:08Z","timestamp":1759609628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394019303799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":160,"alternative-id":["S0304394019303799"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2019.134306","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral versus central nervous system APOE in Alzheimer\u2019s disease: Interplay across the blood-brain barrier","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2019.134306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"134306"}}